Cephalon To File Treanda For Two Oncology Indications This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is on track to file chronic lymphocytic leukemia indication in Q3, followed by non-Hodgkin’s lymphoma in Q4.